Abstract
Pretreatment with quipazine, a serotonin agonist, and clomipramine, a selective serotonin neuronal uptake blocker, was found to potentiate the cataleptic effect of haloperidol in a dose-dependent manner in rats. Pretreatment with methysergide, a serotonin antagonist, reduced the cataleptic effect of haloperidol. The results indicate that the cataleptic effect of neuroleptics depends on the balance between the dopaminergic and serotonergic systems, and that the serotonergic system exerts an inhibitory influence on the dopaminergic system.
Similar content being viewed by others
References
Chase, T. N., Murphy, D. L.: Serotonin and central nervous system function. In: Annual review of pharmacology, vol 13. H. W. Elliot, R. Okun, and R. George, eds., pp. 181–197. California: Annual Reviews Inc. 1973
Costall, B., naylor, R. J.: Stereotyped and circling behavior induced by dopaminergic agonists after lesions of the mid brain raphe nuclei. Eur. J. Pharmacol. 29, 206–222 (1974a)
Costall, B., Naylor, R. J.: Mesolimbic involvement with behavioural effects indicating antipsychotic activity. Eur. J. Pharmacol. 27, 46–58 (1974b)
Franz, D. N.: Drugs for Parkinson's disease; centrally acting muscle relaxants. In: The pharmacological basis of therapeutics, L. S. Goodman and A. Gilman, eds., pp. 227–244. New York: Macmillan Publishing Co., Inc. 1975
Hamon, M., Bourgoin, S., Enjaber, A., Bockaert, J., Hery, F., Ternaux, J. P., Glowinski, J.: The effects of quipazine on 5-HT metabolism in the rat brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 294, 99–108 (1976)
Hong, E., Sancilio, L. F., Vargas, R., Pardo, E. G.: Similarities between the pharmacological actions of quipazine and serotonin. Eur. J. Pharmacol. 6, 274–280 (1969)
Kostowski, W., Gumulka, W., Czlonkowski, A.: Reduced cataleptogenic effects of some neuroleptics in rats with lesioned mid brain raphe and treated with p-chlorophenylalanine. Brain Res. 48, 443–446 (1972)
Malec, D., Langwinski, R., Kruszewska, A.: The role of 5-HT in the mechanism of amphetamine action. Pol. J. Pharmacol. Pharm. 27, 155–160 (1975)
Mattysse, S.: Antipsychotic drug actions: a clue to the neuropathology of schizophrenia? Fed. Proc. 32, 200–205 (1973)
Medon, P. J., Leeling, J. L., Phillips, B. M.: Influence of quipazine, a potential antiparkinsonian agent, on the uptake of 3H-dopamine and 3H-serotonin into rat striatal tissue in vitro. Life Sci. 13, 685–691 (1973)
Parizek, J., Hassler, R., Bak, I. J.: Light and electron microscopic autoradiography of substantia nigra of rat after intraventricular administration of tritium labeled norepinephrine, serotonin, dopamine and the precursors. Z. Zellforsch. Mikrosk. Anat 115, 137–148 (1971)
Pollin, W., Cardon, P. V., Kety, S.: Effects of amino acid feedings in schizophrenic patients treated with iproniazid. Science 133, 104–105 (1961)
Rodriguez, R., Rojas-Ramirez, J. A., Drucker-Colin, R. R.: Serotonin-like actions of quipazine on the central nervous system. Eur. J. Pharmacol. 24, 164–171 (1973)
Ross, S. B., Renyi, A. L.: Tricyclic antidepressant agents. I. Comparison of the inhibition of the uptake of 3H-noradrenaline and 14C-5-hydroxytryptamine in slices and crude synaptosome preparations of the midbrain-hypothalamus region of the rat brain. Acta Pharmacol. Toxicol. 36, 382–394 (1975)
Ross, S. B., Renyi, A. L., Ogren, S. O.: Inhibition of the uptake of noradrenaline and 5-hydroxytryptamine by chlorphentermine and chlorimipramine. Eur. J. Pharmacol. 17, 107–112 (1972)
Snyder, S. H., Banerjee, S. P., Yamamura, H. I., Greenberg, D.: Drugs, neurotransmitters, and schizophrenia. Science 184, 1243–1253 (1974)
Wyatt, R. J., Vaughan, T., Galanter, M., Green, R., Kaplan, J.: Behavioral changes of chronic schizophrenic patients given l-5-hydroxytryptophan. Science 177, 1124–1126 (1972)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Balsara, J.J., Jadhav, J.H. & Chandorkar, A.G. Effect of drugs influencing central serotonergic mechanisms on haloperidol-induced catalepsy. Psychopharmacology 62, 67–69 (1979). https://doi.org/10.1007/BF00426037
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00426037